COG AHOD1331: A Randomized Phase III Study of Brentuximab vedotin (IND#117117) for Newly Diagnosed Classical Hodgkin Lymphoma (cHL) in Children and Adolescents

Project: Research project

Project Details

StatusActive
Effective start/end date10/16/1512/31/20

Funding

  • Children's Hospital of Philadelphia